0Senior Physician in the Field of Immunotherapy (m/f/d)
Universitätsklinikum Tübingen | Germany | 72xxx Tübingen | Temporary contract | Full time | Published since: 15.06.2026 on stepstone.de

Senior Physician in the Field of Immunotherapy (m/f/d)

Branch: Public relations Branch: Public relations


The University Hospital Tübingen is a leading center of German university medicine. Around 75,000 patients become stationary and approx. 380,000 outpatiently treated. With around 10,600 employees, it is the largest employer in the region. The quality of the medical care is certified with the quality seal of the KTQ. About KKE Translational Immunology In the KKE Translational Immunology as a cross-disciplinary department, novel immune therapies for cancer patients are developed and clinically tested. The Department of Internal Medicine of the UKT has the full level of training in the field of internal medicine and the various sub-areas including hematology and oncology. Senior Consultant (w/m/d) Medical University Hospital, Internal Medicine, KKE Translational Immunology, Kennz. 7566 Full time: 100 % | Period: 2 years1 | Start of work: next possible | Application deadline: 16.07.2026 | TV-Ä i.d.R. Ä32

Your tasks • Your profile • What we offer

The University Hospital Tübingen is a leading center of German university medicine. Around 75,000 patients become stationary and approx. 380,000 outpatiently treated. With around 10,600 employees, it is the largest employer in the region. The quality of the medical care is certified with the quality seal of the KTQ. About KKE Translational Immunology In the KKE Translational Immunology as a cross-disciplinary department, novel immune therapies for cancer patients are developed and clinically tested. The Department of Internal Medicine of the UKT has the full level of training in the field of internal medicine and the various sub-areas including hematology and oncology. Senior Consultant (w/m/d) Medical University Hospital, Internal Medicine, KKE Translational Immunology, Kennz. 7566 Full time: 100 % | Period: 2 years1 | Start of work: next possible | Application deadline: 16.07.2026 | TV-Ä i.d.R. Ä32

Care of patients in ongoing and newly established immunotherapy studies in peptide vaccination and antibody therapy for haematological neoplasias and solid tumors The focus is on the treatment of patients in the outpatient and outpatient area, as well as the coordination of medical staff and the assistance of studies Contribution to the design and creation of study documents for new therapeutic concepts Participation in the department's scientific projects and student teaching in the field of immunology / immunotherapy is desirable

Closed further education Internal medicine and experience in the care of oncological patients, e.g. by detecting the focus of hematology and oncology The achievement of habilitation is not a precondition, but is actively supported if desired. Ideally already experience in conducting clinical trials and a current GCP certificate Interest in a leadership task in a collegial and dedicated team Empathic and patient-oriented appearance and enthusiasm for translational medicine Proven basic qualification in the field of leadership or willingness to acquire these

Modern environment: innovative university clinic, state-of-the-art technology, international top research, excellent perspectives Equal opportunities & diversity: active promotion of equality, internal bodies as a point of contact, network for conflict resolution Internationality: Cultural & Generational Diversity in the Team, Support by Language Courses, Integration Programmes (Pflege) Research: top-level research, promotion from PhD to professorship

Location

ava Universitätsklinikum Tübingen
Geissweg 5, 72076  Tübingen
Germany

The text of this ad was translated from German into English using an automatic translation system and may contain semantic and lexical errors. Therefore, it should be used for introductory purposes only. For more detailed information, see the original text of the ad at the link below.

For more information read the original ad

Permanent link to this ad

Ad Id